Noémie S. Minczeles

Peptide Receptor Radionuclide Therapy With 177Lu-DOTATATE for Symptomatic Control of Refractory Carcinoid Syndrome

Wouter T. Zandee, Tessa Brabander, Anela Blažević et al. · The Journal of Clinical Endocrinology & Metabolism · 2021 · 53 citations · Full text

Efficacy and safety of peptide receptor radionuclide therapy with [177Lu]Lu-DOTA-TATE in 15 patients with progressive treatment-refractory meningioma

Noémie S. Minczeles, Eelke M. Bos, Reinoud C. de Leeuw et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2022 · 31 citations

Pharmacology, Radiopharmaceutical Therapy, Radiology +1

Dose-Limiting Bone Marrow Toxicities After Peptide Receptor Radionuclide Therapy Are More Prevalent in Women Than in Men

Noémie S. Minczeles, Wouter W. de Herder, Mark Konijnenberg et al. · Clinical Nuclear Medicine · 2022 · 19 citations

Induction therapy with 177Lu-DOTATATE procures long-term survival in locally advanced or oligometastatic pancreatic neuroendocrine neoplasm patients

Noémie S. Minczeles, Casper H.J. van Eijck, Marjon J. van Gils et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2022 · 18 citations · Full text

Long-Term Outcomes of Submaximal Activities of Peptide Receptor Radionuclide Therapy with¹⁷⁷Lu-DOTATATE in Neuroendocrine Tumor Patients

Noémie S. Minczeles, Wouter W. de Herder, Richard A. Feelders et al. · Journal of Nuclear Medicine · 2022 · 14 citations · Full text